Journal
JOURNAL OF CROHNS & COLITIS
Volume 6, Issue 5, Pages 610-616Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.crohns.2011.12.007
Keywords
Biological therapy; Crohn's disease; Infliximab; Psoriasis; Tumor necrosis factor-alpha inhibitors
Categories
Ask authors/readers for more resources
Although therapy with tumor necrosis factor-alpha inhibitors (anti-TNF) provides beneficial effects in different immune inflammatory disorders, paradoxical cases of anti-THE-induced psoriasis have increasingly been reported, mostly in the setting of rheumatologic diseases. To date, less than 50 cases of infliximab-induced psoriasis in inflammatory bowel disease patients have been described. The present report was aimed at describing two new cases of infliximab-induced psoriasis during therapy for Crohn's disease and at carrying out a review on this intriguing phenomenon. (C) 2011 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available